0 Comments
0 Shares
409 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Congestive Heart Failure Drugs Market Future Scope, Competitive Landscape and Comprehensive Forecast to 2033Congestive Heart Failure Drugs Industry Outlook: Straits Research has added a report titled “Global Congestive Heart Failure Drugs Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Congestive Heart Failure Drugs in various industrial applications and geographies. This helps the key...0 Comments 0 Shares 566 Views 0 Reviews
-
Heart Failure Drugs Market Research Report: Size, Trends, Growth and Forecast 2026–2036NEWARK, Del., Aug. 20, 2026 — The global Heart Failure Drugs Market is expanding as healthcare providers increasingly adopt guideline-directed medical therapy and earlier pharmacological intervention for patients with heart failure. According to Future Market Insights (FMI), the market is projected to grow from USD 18.8 billion in 2026 to USD 37.0 billion by 2036, registering a 7.0% CAGR...0 Comments 0 Shares 356 Views 0 Reviews
-
How Rising Heart Failure Prevalence and Novel Therapeutics Are Driving the US Heart Failure Drugs MarketThe US Heart Failure Drugs market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of heart failure and improve patient outcomes. The market was valued at USD 6.14 billion in 2024 and is projected to reach USD 8.14 billion by 2035, growing at a CAGR of 2.6%. The US Heart Failure...0 Comments 0 Shares 257 Views 0 Reviews
-
Dobutamine Market Growing at 5.8% CAGR Through 2034According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...0 Comments 0 Shares 2K Views 0 Reviews